Biohope have presented a poster in the framework of the BST (Basic Science in Transplantation) congress that took place from October 11th to 13th in Rotterdam: “Immunobiogram: a new immunological tool to personalize immunosuppressive therapy in kidney transplant recipients”. It shows the biotechnological principles of the Immunobiogram (IMBG) and the results of the clinical study BH-Pilot 2015, [...]
Biohope will present a poster in the framework of the BST (Basic Science in Transplantation) congress that takes place from October 11th to 13th in Rotterdam. It shows the biotechnological principles of the Immunobiogram (IMBG) and the results of the clinical study BH-Pilot, in which the IMBG was tested in 70 patients with a renal [...]
The TRANSBIO clinical study has started with inclusion of the first patient in the Hospital Puerta de Hierro (Madrid, Spain) on the 12th of June 2018, with Dr. José María Portoles as Principal Investigator. The University Hospital Puerta de Hierro was created in 1964 and it is a general hospital of first level that fulfils a triple function: [...]
On Tuesday 3th of July at TTS 2018, the promising final Immunobiogram results coming from BH-Pilot clinical study will be presented in a lunch&learn session by Dr. Julio Pascual, Head of Nephrology Department in Hospital del Mar, Barcelona, and Dr. Isabel Portero, Biohope CEO: Immunobiogram® a novel Precision Medicine Tool to help guidance of immunosuppression in Renal [...]